Department of Radiation Oncology, University of Mississippi Medical Center, 350 West Woodrow Wilson Ave. Suite 1600, Jackson, MS, 39216, USA.
BMC Pulm Med. 2023 Oct 9;23(1):379. doi: 10.1186/s12890-023-02667-2.
Currently, radiation therapy treatment planning system intends biological optimization that relies heavily upon plan metrics from tumor control probability (TCP) and normal tissue complication probability (NTCP) modeling. Implementation and expansion of TCP and NTCP models with alternative data is an important step towards reliable radiobiological treatment planning. In this retrospective single institution study, the treatment charts of 139 lung cancer patients treated with chemo-radiotherapy were reviewed and correlated dosimetric predictors with the incidence of esophagitis and established NTCP model of esophagitis grade 1 and 2 for lung cancer patients.
Esophagus is an organ at risk (OAR) in lung cancer radiotherapy (RT). Esophagitis is a common toxicity induced by RT. In this study, dose volume parameters V (V: percentage esophageal volume receiving ≥ x Gy) and mean esophagus dose (MED) as quantitative dose-volume metrics, the esophagitis grade 1 and 2 as endpoints, were reviewed and derived from the treatment planning system and the electronic medical record system. Statistical analysis of binary logistic regression and probit were performed to have correlated the probability of grade 1 and 2 esophagitis to MED and V. IBM SPSS software version 24 at 5% significant level (α = 0.05) was used in the statistical analysis.
The probabilities of incidence of grade 1 and 2 esophagitis proportionally increased with increasing the values of V and MED. V, V, V, V and MED are statistically significant good dosimetric predictors of esophagitis grade 1. 50% incidence probability (TD) of MED for grade 1 and 2 esophagitis were determined. Lyman Kutcher Burman model parameters, such as, n, m and TD, were fitted and compared with other published findings. Furthermore, the sigmoid shaped dose responding curve between probability of esophagitis grade 1 and MED were generated respecting to races, gender, age and smoking status.
V, V, V and V were added onto Quantitative Analysis of Normal Tissue Effects in the clinic, or QUANTEC group's dose constrains of V, V, V and MED. Our findings may be useful as both validation of 3-Dimensional planning era models and also additional clinical guidelines in treatment planning and plan evaluation using radiobiology optimization.
目前,放射治疗计划系统旨在进行生物学优化,该优化严重依赖于肿瘤控制概率 (TCP) 和正常组织并发症概率 (NTCP) 建模的计划指标。使用替代数据来实现和扩展 TCP 和 NTCP 模型是实现可靠放射生物学治疗计划的重要步骤。在这项回顾性单机构研究中,对 139 例接受化疗放疗的肺癌患者的治疗图表进行了回顾,并将剂量学预测因子与食管炎的发生率相关联,并为肺癌患者建立了食管炎 1 级和 2 级的 NTCP 模型。
食管是肺癌放射治疗 (RT) 的危及器官 (OAR)。食管炎是 RT 引起的常见毒性。在这项研究中,体积剂量参数 V(V:食管体积接受≥x Gy 的百分比)和平均食管剂量 (MED) 作为定量剂量-体积指标,食管炎 1 级和 2 级作为终点,从治疗计划系统和电子病历系统中进行了回顾和推导。采用二项逻辑回归和概率分析对 MED 和 V 与 1 级和 2 级食管炎的概率进行相关性分析。采用 IBM SPSS 软件版本 24,在 5%显著水平(α=0.05)下进行统计学分析。
随着 V 和 MED 值的增加,1 级和 2 级食管炎的发生率呈比例增加。V、V、V、V 和 MED 是食管炎 1 级的统计学上显著的良好剂量学预测因子。确定了 MED 对 1 级和 2 级食管炎的 50%发生率概率 (TD)。拟合了 Lyman Kutcher Burman 模型参数,如 n、m 和 TD,并与其他已发表的结果进行了比较。此外,根据种族、性别、年龄和吸烟状况,生成了食管炎 1 级和 MED 之间概率呈 S 形剂量反应曲线。
V、V、V 和 V 被添加到临床中的正常组织效应定量分析中,或者 QUANTEC 组的 V、V、V 和 MED 剂量限制中。我们的研究结果可能有助于验证 3D 计划时代模型,以及在使用放射生物学优化进行治疗计划和计划评估时提供额外的临床指南。